LAMEA Stroke Management Market By Type (Diagnostics - Computed Tomography Scan, Magnetic Resonance Imaging, Echocardiography, Carotid Ultrasound, Cerebral Angiography, Electrocardiography; Therapeutics - Tissue Plasminogen Activator, Anticoagulant, Antiplatelet), Application (Ischemic, Haemorrhagic)

The Latin America, Middle East and Africa Stroke Management Market would witness market growth of 8.0% CAGR during the forecast period (2018 – 2024). Stroke is a medical emergency which occurs when the flow of the blood is restricted to the brain and as a result, brain cells start dying. Rise in incidence and prevalence of chronic diseases has been a major factor that is responsible for the growth of the stroke management market. Additionally, growing geriatric population, which is highly susceptible to strokes, growing diabetic population and usage of tobacco are other factors that are driving the growth of the market. However, the cost associated with the treatment and stringent government regulations pertaining to the approval of new and advances devices and drugs would limit the market growth. Rising investments to upgrade healthcare systems and demand for technologically advanced devices for rapid & accurate distribution of medicines are the factors that are driving the market in the region. Research and development activities in the region would further add to the market attractiveness in the region.

Click Here For Free Insights:

Based on Application, the market is segmented into Ischemic Stroke and Hemorrhagic Stroke. Based on Type, the market is segmented into Diagnostics and Therapeutics. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, B. Braun Melsungen Ag, Boston Scientific Corporation, Cardinal Health, Inc., Ge Healthcare, Glaxosmithkline Plc, Medtronic Plc., Siemens Aktiengesellschaft, Merck & Co., Inc., and Bristol-Myers Squibb Company.

Scope of the Study

Market Segmentation:

By Type

• Diagnostics

• Computed Tomography Scan (CT Scan)
• Magnetic Resonance Imaging (MRI)
• Echocardiography
• Carotid Ultrasound
• Cerebral Angiography
• Electrocardiography
• Others

• Therapeutics

• Tissue Plasminogen Activator
• Anticoagulant
• Antiplatelet
• Other Therapeutics Type

By Application                                                  

• Ischemic Stroke
• Hemorrhagic Stroke

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Companies Profiled

• ABBOTT Laboratories
• B. Braun Melsungen Ag
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Ge Healthcare
• Glaxosmithkline Plc
• Medtronic Plc
• Siemens Aktiengesellschaft
• Merck & Co., Inc.
• Bristol-Myers Squibb Company

Chapter 1.    Market Scope & Methodology
1.1    Market Definition
1.2    Objectives
1.3    Market Scope
1.4    Segmentation
1.4.1    LAMEA Stroke Management Market, by Type
1.4.2    LAMEA Stroke Management Market, by Application
1.4.3    LAMEA Stroke Management Market, by Country
1.5    Methodology for the research
Chapter 2.    Market Overview
2.1    Introduction
2.1.1    Overview
2.1.2    Players Outlook for the Market
2.2    Key Factors Impacting the Market
2.2.1    Market Drivers
2.2.2    Market Restraints
Chapter 3.    LAMEA Stroke Management Market by Type
3.1.1    LAMEA Diagnostics Stroke Management Market by Country
3.1.1.1    LAMEA Stroke Management Market by Diagnostics Type
3.1.1.1.1    LAMEA Stroke Management Computed Tomography Scan (CT Scan) Market by Country
3.1.1.1.2    LAMEA Stroke Management Magnetic Resonance Imaging (MRI) Market by Country
3.1.1.1.3    LAMEA Stroke Management Echocardiography Market by Country
3.1.1.1.4    LAMEA Stroke Management Carotid Ultrasound Market by Country
3.1.1.1.5    LAMEA Stroke Management Cerebral Angiography Market by Country
3.1.1.1.6    LAMEA Stroke Management Electrocardiography Market by Country
3.1.1.1.7    LAMEA Other Diagnostics Type Stroke Management Market by Country
3.1.2    LAMEA Therapeutics Stroke Management Market by Country
3.1.2.1    LAMEA Stroke Management Market by Therapeutics Type
3.1.2.1.1    LAMEA Tissue Plasminogen Activator Stroke Management Market by Country
3.1.2.1.2    LAMEA Anticoagulant Stroke Management Market by Country
3.1.2.1.3    LAMEA Antiplatelet Stroke Management Market by Country
3.1.2.1.4    LAMEA Other Therapeutics Type Stroke Management Market by Country
Chapter 4.    LAMEA Stroke Management Market by Application
4.1.1    LAMEA Ischemic Stroke Management Market by Country
4.1.2    LAMEA Hemorrhagic Stroke Management Market by Country
Chapter 5.    LAMEA Stroke Management Market by Country
5.1    Brazil Stroke Management Market
5.1.1    Brazil Stroke Management Market by Type
5.1.1.1    Brazil Stroke Management Market by Diagnostics Type
5.1.1.2    Brazil Stroke Management Market by Therapeutics Type
5.1.2    Brazil Stroke Management Market by Application
5.2    Argentina Stroke Management Market
5.2.1    Argentina Stroke Management Market by Type
5.2.1.1    Argentina Stroke Management Market by Diagnostics Type
5.2.1.2    Argentina Stroke Management Market by Therapeutics Type
5.2.2    Argentina Stroke Management Market by Application
5.3    UAE Stroke Management Market
5.3.1    UAE Stroke Management Market by Type
5.3.1.1    UAE Stroke Management Market by Diagnostics Type
5.3.1.2    UAE Stroke Management Market by Therapeutics Type
5.3.2    UAE Stroke Management Market by Application
5.4    Saudi Arabia Stroke Management Market
5.4.1    Saudi Arabia Stroke Management Market by Type
5.4.1.1    Saudi Arabia Stroke Management Market by Diagnostics Type
5.4.1.2    Saudi Arabia Stroke Management Market by Therapeutics Type
5.4.2    Saudi Arabia Stroke Management Market by Application
5.5    South Africa Stroke Management Market
5.5.1    South Africa Stroke Management Market by Type
5.5.1.1    South Africa Stroke Management Market by Diagnostics Type
5.5.1.2    South Africa Stroke Management Market by Therapeutics Type
5.5.2    South Africa Stroke Management Market by Application
5.6    Nigeria Stroke Management Market
5.6.1    Nigeria Stroke Management Market by Type
5.6.1.1    Nigeria Stroke Management Market by Diagnostics Type
5.6.1.2    Nigeria Stroke Management Market by Therapeutics Type
5.6.2    Nigeria Stroke Management Market by Application
5.7    Rest of LAMEA Stroke Management Market
5.7.1    Rest of LAMEA Stroke Management Market by Type
5.7.1.1    Rest of LAMEA Stroke Management Market by Diagnostics Type
5.7.1.2    Rest of LAMEA Stroke Management Market by Therapeutics Type
5.7.2    Rest of LAMEA Stroke Management Market by Application
Chapter 6.    Company Profiles
6.1    B. Braun Melsungen AG.
6.1.1    Company Overview
6.1.2    Financial Analysis
6.1.3    Segmental Analysis
6.1.4    Research & Development Expense
6.2    ABBOTT
6.2.1    Company Overview
6.2.2    Financial Analysis
6.2.3    Regional & Segmental Analysis
6.2.4    Research & Development Expense
6.3    Cardinal Health
6.3.1    Company Overview
6.3.2    Financial Analysis
6.3.3    Segmental Analysis
6.4    Medtronic Plc.
6.4.1    Company Overview
6.4.2    Financial Analysis
6.4.3    Segmental and Regional Analysis
6.4.4    Research & Development Expense
6.5    General Electric (GE) (GE Healthcare)
6.5.1    Company Overview
6.5.2    Financial Analysis
6.5.3    Segmental and Regional Analysis
6.5.4    Research & Development Expense
6.6    Siemens Healthineers
6.6.1    Company Overview
6.6.2    Financial Analysis
6.6.3    Segmental Analysis
6.6.4    Research & Development Expense
6.7    Bristol-Myers Squibb
6.7.1    Company Overview
6.7.2    Financial Analysis
6.7.3    Regional Analysis
6.7.4    Research & Development Expense
6.8    Merck & Company Inc.
6.8.1    Company Overview
6.8.2    Financial Analysis
6.8.3    Segmental Analysis
6.8.4    Research & Development Expense
6.9    Glaxosmithkline Plc.
6.9.1    Company Overview
6.9.2    Financial Analysis
6.9.3    Segmental Analysis
6.9.4    Research & Development Expense

TABLE 1    LAMEA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 2    LAMEA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 3    LAMEA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 4    LAMEA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 5    LAMEA DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 6    LAMEA DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 7    LAMEA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 8    LAMEA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 9    LAMEA STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 10    LAMEA STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 11    LAMEA STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 12    LAMEA STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 13    LAMEA STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 14    LAMEA STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 15    LAMEA STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 16    LAMEA STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 17    LAMEA STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 18    LAMEA STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 19    LAMEA STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 20    LAMEA STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 21    LAMEA OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 22    LAMEA OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 23    LAMEA THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 24    LAMEA THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 25    LAMEA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 26    LAMEA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 27    LAMEA TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 28    LAMEA TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 29    LAMEA ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 30    LAMEA ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 31    LAMEA ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 32    LAMEA ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 33    LAMEA OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 34    LAMEA OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 35    LAMEA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 36    LAMEA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 37    LAMEA ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 38    LAMEA ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 39    LAMEA HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 40    LAMEA HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 41    LAMEA STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 42    LAMEA STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 43    BRAZIL STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 44    BRAZIL STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 45    BRAZIL STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 46    BRAZIL STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 47    BRAZIL STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 48    BRAZIL STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 49    BRAZIL STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 50    BRAZIL STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 51    BRAZIL STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 52    BRAZIL STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 53    ARGENTINA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 54    ARGENTINA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 55    ARGENTINA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 56    ARGENTINA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 57    ARGENTINA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 58    ARGENTINA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 59    ARGENTINA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 60    ARGENTINA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 61    ARGENTINA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 62    ARGENTINA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 63    UAE STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 64    UAE STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 65    UAE STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 66    UAE STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 67    UAE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 68    UAE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 69    UAE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 70    UAE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 71    UAE STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 72    UAE STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 73    SAUDI ARABIA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 74    SAUDI ARABIA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 75    SAUDI ARABIA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 76    SAUDI ARABIA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 77    SAUDI ARABIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 78    SAUDI ARABIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 79    SAUDI ARABIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 80    SAUDI ARABIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 81    SAUDI ARABIA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 82    SAUDI ARABIA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 83    SOUTH AFRICA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 84    SOUTH AFRICA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 85    SOUTH AFRICA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 86    SOUTH AFRICA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 87    SOUTH AFRICA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 88    SOUTH AFRICA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 89    SOUTH AFRICA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 90    SOUTH AFRICA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 91    SOUTH AFRICA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 92    SOUTH AFRICA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 93    NIGERIA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 94    NIGERIA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 95    NIGERIA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 96    NIGERIA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 97    NIGERIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 98    NIGERIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 99    NIGERIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 100    NIGERIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 101    NIGERIA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 102    NIGERIA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 103    REST OF LAMEA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 104    REST OF LAMEA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 105    REST OF LAMEA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 106    REST OF LAMEA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 107    REST OF LAMEA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 108    REST OF LAMEA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 109    REST OF LAMEA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 110    REST OF LAMEA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 111    REST OF LAMEA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 112    REST OF LAMEA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 113    KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 114    KEY INFORMATION – ABBOTT
TABLE 115    KEY INFORMATION – CARDINAL HEALTH
TABLE 116    BUSINESS SEGMENT – CARDINAL HEALTH
TABLE 117    KEY INFORMATION – MEDTRONIC PLC
TABLE 118    KEY INFORMATION – MEDTRONIC
TABLE 119    KEY INFORMATION – GENERAL ELECTRIC (GE)
TABLE 120    KEY INFORMATION - SIEMENS HEALTHINEERS
TABLE 121    KEY INFORMATION - BRISTOL-MYERS SQUIBB
TABLE 122    KEY INFORMATION - MERCK & COMPANY INC.
TABLE 123    KEY INFORMATION - GLAXOSMITHKLINE PLC.